Paper27210751
Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
Hamilton A and 5 others. Cell Rep, 2016. Cited by 94 papers, by iCite.
Cite this record
ConductScience Library. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Papers, record 27210751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27210751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cognitive Dysfunction | Major topic |
| Imidazoles | Major topic |
| Pyridines | Major topic |
| Receptor, Metabotropic Glutamate 5 | Major topic |
| Amyloid beta-Peptides | |
| Animals | |
| Disease Models, Animal | |
| Memory | |
| Mice, Inbred C57BL | |
| Mice, Transgenic | |
| Plaque, Amyloid |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOP-119437 | CIHR | Canada | PubMed |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42745993 | Targeting protein aggregate co-pathologies in neurodegeneration: a viable therapeutic strategy? | Mol Neurodegener Adv | 2026 | https://conductscience.org/library/papers/42745993 | PubMed |
| 42645765 | Calcium dysregulation in neurovascular function in Alzheimer's disease: mechanisms, therapeutic targets. | Geroscience | 2026 | https://conductscience.org/library/papers/42645765 | PubMed |
| 41606687 | Presymptomatic pharmacological inhibition of mGluR5 improves survival in a mouse model of prion diseases. | Acta Neuropathol Commun | 2026 | https://conductscience.org/library/papers/41606687 | PubMed |
| 41097999 | Combined Treatment with Minocycline and an mGluR5 Antagonist Alters Resting EEG Spectral Power, but Not Sound-Evoked Responses, in a Mouse Model of Fragile X Syndrome. | ASN Neuro | 2025 | https://conductscience.org/library/papers/41097999 | PubMed |
| 41073451 | Targeting metabotropic glutamate receptors for symptomatic and disease-modifying treatment in Parkinson's disease. | NPJ Parkinsons Dis | 2025 | https://conductscience.org/library/papers/41073451 | PubMed |
| 41025328 | Modeling presynaptic inhibition by the amyloid precursor protein demonstrates one potential mechanism for preventing runaway synaptic modification in Alzheimer's disease. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/41025328 | PubMed |
| 40388923 | The interaction between neurotransmitter receptor activity and amyloid-β pathology in Alzheimer's disease. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40388923 | PubMed |
| 40329311 | Assessment of the relationship between synaptic density and metabotropic glutamate receptors in early Alzheimer's disease: a multi-tracer PET study. | Alzheimers Res Ther | 2025 | https://conductscience.org/library/papers/40329311 | PubMed |
| 40047257 | Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40047257 | PubMed |
| 39974631 | Unveiling the Interplay: Neurovascular Coupling, Astrocytes and G Protein-Coupled Receptors in Alzheimer's Disease. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/39974631 | PubMed |
| 39353038 | Amyloid-β oligomers trigger sex-dependent inhibition of GIRK channel activity in hippocampal neurons in mice. | Sci Signal | 2024 | https://conductscience.org/library/papers/39353038 | PubMed |
| 39214708 | Cells and Molecules Underpinning Cannabis-Related Variations in Cortical Thickness during Adolescence. | J Neurosci | 2024 | https://conductscience.org/library/papers/39214708 | PubMed |
| 38941064 | Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/38941064 | PubMed |
| 38217040 | Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [18F]PSS232 PET/MRI study. | Alzheimers Res Ther | 2024 | https://conductscience.org/library/papers/38217040 | PubMed |
| 38053635 | Amyloid-β1-42 oligomers enhance mGlu5R-dependent synaptic weakening via NMDAR activation and complement C5aR1 signaling. | iScience | 2023 | https://conductscience.org/library/papers/38053635 | PubMed |
| 38012296 | Targeting synapse function and loss for treatment of neurodegenerative diseases. | Nat Rev Drug Discov | 2024 | https://conductscience.org/library/papers/38012296 | PubMed |
| 37759748 | Functional Interaction between Adenosine A2A and mGlu5 Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu5R Binding in Mouse Hippocampus and Neuroblastoma Cell Line. | Biomolecules | 2023 | https://conductscience.org/library/papers/37759748 | PubMed |
| 37566031 | Genetic Downregulation of the Metabotropic Glutamate Receptor Type 5 Dampens the Reactive and Neurotoxic Phenotype of Adult ALS Astrocytes. | Cells | 2023 | https://conductscience.org/library/papers/37566031 | PubMed |
| 37055181 | VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease. | J Neurosci | 2023 | https://conductscience.org/library/papers/37055181 | PubMed |
| 36982982 | Co-Expression Network Analysis Identifies Molecular Determinants of Loneliness Associated with Neuropsychiatric and Neurodegenerative Diseases. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982982 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27210751
GET https://conductscience.org/api/papers/v1/27210751/cited_by?page=2